key: cord-0782177-q6bzwmak
authors: Dunay, G. A.; Barroso, M.; Woidy, M.; Danecka, M. K.; Engels, G.; Hermann, K.; Neumann, F. S.; Paul, K.; Beime, J.; Escherich, G.; Fehse, K.; Grinstein, L.; Haniel, F.; Haupt, L. J.; Hecher, L.; Kehl, T.; Kemen, C.; Kemper, M. J.; Kobbe, R.; Kohl, A.; Klokow, T.; Noerz, D.; Olfe, J.; Schlenker, F.; Schmiesing, J.; Schrum, J.; Sibbertsen, F.; Stock, P.; Tiede, S.; Vettorazzi, E.; Zazara, D. E.; Zapf, A.; Luetgehetmann, M.; Oh, J.; Mir, T. S.; Muntau, A. C.; C19.CHILD Study Group,; Gersting, S. W.
title: Long term antibody response to SARS-CoV-2 in children
date: 2022-02-11
journal: nan
DOI: 10.1101/2022.02.11.22270611
sha: 229f6e698577267437a2827ccd3d894882c5b0a9
doc_id: 782177
cord_uid: q6bzwmak

Almost two years into the pandemic and with vaccination of children significantly lagging behind adults, long-term pediatric humoral immune responses to SARS-CoV-2 are understudied. The C19.CHILD Hamburg (COVID-19 Child Health Investigation of Latent Disease) Study is a prospective cohort study designed to identify and follow up children and their household contacts infected in the early 2020 first wave of SARS-CoV-2 infections. We screened 6113 children <18 years by nasopharyngeal swab-PCR in a low-incidence setting after general lockdown, from May 9 to June 30, 2020. 4657 participants underwent antibody testing. Positive tests were followed up by repeated PCR and serological testing of all household contacts over 6 months. In total, the study identified 67 seropositive children (1.44 %), the median time after infection at first presentation was 83 days post-symptom onset (PSO). Follow up of household contacts showed incomplete seroconversion in most families, with higher rates in families with adult index cases compared to pediatric index cases (OR: 1.79, P=0.047). Most importantly, children showed sustained seroconversion up to nine months PSO, and serum antibody concentrations persistently surpassed adult levels (ratio serum IgG Spike children vs. adults 90 days PSO: 1.75, P<0.001, 180 days: 1.38, P=0.01, 270 days: 1.54, P=0.001). In a low-incidence setting, SARS-CoV-2 infection and humoral immune response present distinct patterns in children including higher antibody levels, and lower seroconversion rates in families with pediatric index cases. Children show long-term SARS-CoV-2 antibody responses. These findings are relevant to novel variants with increased disease burden in children, as well as for the planning of age-appropriate vaccination strategies.

We screened 6113 children under eighteen years of age in the Free and Hanseatic City of Hamburg, Germany (population 1,845,017 on April 30, 2020) within a defined time period (May 11 -June 30, 2020) and included 5908 study participants from 4506 families in the C19.CHILD study. Children were recruited regardless of the presence or absence of any COVID-19 symptoms. The study included 3145 (53 %) volunteers recruited through the C19.CHILD Study Clinic at Kinder-UKE and 2763 (47 %) subjects who presented at one of the Hamburg pediatric hospitals for reasons independent of this study. In case of a positive PCR and/or antibody test, children were invited for follow-up tests along with all contact persons living in the same household.

One child tested PCR positive for SARS-CoV-2. Two antibody tests were used for this study. For analysis, the Roche nucleocapsid protein total IgA/IgM/IgG test was defined as screening antibody test (available for 4657 participants, 79 % of total included) and the DiaSorin S1/S2 spike IgG was defined as confirmatory test. A total of 67 children, 1.44 % of all tested, had a positive antibody reaction in both antibody tests. Participants were recalled for a second testing shortly after positive antibody screening, typically within six days (mean 5.8).

Recall testing was available for 50 children, all tests remained positive as determined by both methods Table S2 ).

In this cohort, the likelihood of seroconversion to SARS-CoV-2 increased with age, the mean age of seropositive children was two years higher than that of seronegative children (10.3 vs. 8.3 years, P=0.001, Table   1 ). We observed a continuous age effect, where the probability of seroconversion increased with an odds ratio of 1.11 per year of age (95 % CI: 1.03-1.21, P=0.009 Supplementary Figure 1 ) in the cohort of screened children under eighteen years. Inclusion of more than one child per family created a cluster structure, which we considered by applying mixed logistic regression models. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint Seroconversion rates did not show any gender differences in this cohort ( Table 1) . Children and adolescents recruited in the participating hospitals often suffered from a complex chronic disease (29% indicated an underlying medical condition, detailed in Supplementary Table S1 ). One might expect a high proportion of vulnerable individuals in the C19.CHILD study population regarding infection rates or severity of disease [13] .

However, children with an underlying medical condition representing almost one third of the study cohort did not show a difference in the seroconversion rate ( Participants and their guardians were asked to report on any persistent symptoms associated with COVID-19 in the last 14 days before screening. Notably, the only symptom that was more common in seropositive children was loss of taste (seronegatives 15/4590, 1.3 %, seropositives 3/67, 21.4 %, p=0.001).

We further looked at the effect of self-reported exposure to persons with confirmed SARS-CoV-2 infection on seroconversion rates. Exposure was reported for 119 children from whom antibody tests were also available. Table 2 ).

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint Thirty-eight families were able to identify the first infected person in the household (index case) based on the beginning of symptoms based on a known contact to an infected person. Notably, when comparing seroconversion rates within individual families, we found that they were lower when the index case was younger than eighteen years than for adult index cases (mean seroconversion rate 48.9 % vs. 73.8 %, Figure 1 

Applying logistic regression to model the risk of seroconversion with the type of index case as predictor confirmed these findings (OR: 1.79, 95 % CI: 1.01-3.19, P=0.047).

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint Longitudinal analysis of antibodies showed that almost all children and adults wo were seropositive at the time of the first follow up retained detectable SARS-CoV-2 antibodies at the time of the third follow up six months later (>193 days after symptom onset). This was observed for both types of antibodies measured in this study, All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint with nucleocapsid IgA/IgG/IgM slightly better retained in adults (seropositivity adults 100 % n=36, children 97.6 %, n=41) and spike IgG better retained in children (seropositivity adults 94.4 % n=36, children 100 %, n=41) at six months after screening in those initially positive in both tests.

The spike IgG test allowed for quantitative assessment of serum antibody concentrations. To follow changes in antibody levels of anti-spike IgG over time, statistical modelling using the zero-inflated tweedie-mixed model was applied (Figure 2) . Time points at 90 days, 180 days and 270 days PSO were chosen for comparison between adults and children, matching the observed time frame in the study cohort (Figure 2) All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint

Here, we report the results of the C19.CHILD study, a large prospective seroprevalence study for SARS-CoV-2 targeting children in a low-incidence setting. Previous seroprevalence studies carried out under lockdown have compared seroconversion rates between children and adults, and found these to be lower in children [14] [15] [16] .

These findings must be interpreted with caution because different contact patterns of children under lockdown may play a substantial role. A large, population-based seroepidemiological study out of Wuhan, China, a place of high initial incidence, described similar seroprevalence in children and older age groups [17] . In our cohort, seroprevalence among children increased with age, as had been the case for other cohorts of the ancestral SARS-CoV-2, including a seroprevalence study in a similar time interval from the south of Germany [14, 15, [18] [19] [20] . These findings may have been specific to the ancestral variant of SARS-CoV-2 and the circumstances governing the early 2020 first wave of coronavirus infections including few imported cases followed by lockdown. Subsequent infection waves, including novel viral variants, showed an increase in seropositivity in children [21] , probably based on the reopening of schools and daycare. At the same time comparison of seroprevalence in children to adults and older teenagers became less meaningful with the spread of vaccination [21] .

We have found that in the case of exposure to a confirmed case of SARS-CoV-2 infection, younger children zero to under six years had a relevantly smaller risk of seroconversion than older children. Consistently, lower secondary attack rates have been reported in children than in adults [22] [23] [24] . A large study on SARS-CoV-2 transmission dynamics in two Indian states, which included children, provided evidence that contacts between people of similar age are more likely to lead to infection [25] . Thus, a lack of contact between children and their similar-age peers in a lockdown scenario might explain the differences between our data and studies in similar low-incidence settings [15, 16] compared to seroprevalence studies in places with high initial incidence [17] .

We report that seroconversion rates within families with index persons below the age of eighteen years were considerably lower. In our cohort, we made use of the relatively high availability of data on the index person in each family, as in the early phase of the pandemic the source of infection could still be identified in most cases.

Most contact tracing and household cluster studies of SARS-CoV-2 have suggested a lower risk of transmission by children [25] [26] [27] [28] [29] [30] . In a large population based cohort study spanning the whole of 2020, older children had a lower risk of transmitting SARS-CoV-2 than younger children, but a comparison with adults was not described [31] . Again, these differences may relate to the highly different contact patterns of children under a general All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint lockdown. In Hamburg, Germany, general school and day care closure lasted from March 1 until at least May 18, 2020 and recruitment to the C19.CHILD Study began on May 11, shortly before lockdown was lifted. In this period, contacts for children outside their own families were very limited and incidence of novel SARS-CoV-2 infections was low (Supplementary Figure S2) . Infection of most index persons in the C19.CHILD cohort probably happened before the lockdown, which is supported by patient histories regarding symptomatic illness in late February and early March (Supplementary Table S2 ). Subsequently, spread of infection would mostly have been limited to family clusters. As awareness of COVID-19 was high in the public, it may be assumed that symptomatic children, especially teenagers, would have been isolated at home (to the extent possible). The isolation of adult caregivers, however, may have been more difficult. As a result, less transmission would have occurred from children than adults. Alternatively, a less efficient biological transmission of the virus by children in the lockdown setting could explain our findings. As viral loads in nasopharyngeal swabs appear to be similar in children and adults [32, 33] , differences in respiratory droplet and aerosol formation [34] , respiratory anatomy [35] , or increased tropism of the virus in the upper vs. lower airways in children [36, 37] , could contribute to the suggested differences in virus transmission. It should be noted, that transmission dynamics may be different for more recent variants of SARS-CoV-2. For the B.1.617. (delta) variant, viral loads appeared to be higher than for the B.1.1.7 (alpha) variant [38] , and significantly increased with age [39] . Research on the delta variant [40] , and preliminary reports on the omicron variant [41, 42] Wuhan [17] , as well as in Jiangsu [43] , China, showed antibodies to persist in a majority of cases over six months. However, the authors did not provide data according to time since symptom onset or the age of the participants. Previously, persistence of antibodies in children based on two serological tests 62 days apart was reported, but time since symptom onset was also unknown [44] . One study in a somewhat comparable pediatric All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint cohort showed also detectable IgG levels after six months and also in a single child nine months after infection [45] , however the cohort did not include adult contacts for comparison. A detailed immunological follow up of adults [46] after SARS-CoV-2 infection showed similar results six to eight months PSO. Compared to adult family members, children in our cohort showed on average higher anti-spike IgG antibody levels in early reconvalescence (less than 121 days PSO). This is in contrast to earlier reports showing lower neutralizing activity [47] or similar anti-spike IgG levels [48] compared to adults, albeit addressed in older pediatric subcohorts. Pre-existing memory B cells and natural antibodies [49] or T cell memory [50, 51] in children on account of more frequent common-cold coronavirus infections may lead to quicker and more efficient SARS-CoV-2 specific immune response and thus higher initial antibody concentrations. The same mechanisms might also contribute to the milder clinical course of SARS-CoV-2 that is characteristic in children. Moreover, as demonstrated in our cohort, anti-spike IgG levels remained higher in children than adults over 193 days PSO, even though a more rapid decline in serum antibody concentrations of children was observed initially.

There are limitations to this study. Teenagers were relatively underrepresented when compared to younger children and Hamburg census data. The retrospective nature of serological testing in this study did not allow for confirmation of infection by direct virus detection (PCR), therefore seropositivity is used as a surrogate marker for past infection. Furthermore, PCR test results from study participants from the time of infection were not available and index cases in family clusters were identified based on patient history of symptomatic illness (Supplementary Table S2) . A selection bias needs to be considered when interpreting our findings. First, our study included over 50 % volunteers, second, blood draws were more likely to have been carried out in older children. In this study, no serum neutralization tests have been performed. Instead, seropositivity was defined based on two different serum antibody tests, both of which have shown good correlation with plaque reduction neutralization tests [52, 53] . While this approach does not measure direct antibody mediated protective immunity, it reduces the probability of false positive tests, especially when multiple family members are assessed. Since the samples used for antibody measurements in this study were obtained after the first 2020 wave of infections, they represent infections with the ancestral SARS-CoV-2 which has now been replaced by more recent viral variants. In spite of this, our data is relevant to antibody responses after vaccination, because all current vaccines are based on inactivated virus or sequences from the ancestral SARS-CoV-2 [54-57]. The setting in which our data was obtained is unique because widespread vaccination and possible repeat infections would complicate designing similar prospective studies in the present day. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 11, 2022. ; https://doi.org/10.1101/2022.02.11.22270611 doi: medRxiv preprint

COVID-19 Dashboard by the Center for Systems Science and Engineering American Medical Association

Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Seroprevalence and humoral immune durability of

Susceptibility to SARS-CoV-2 Infection among Children and Adolescents Compared with Adults: A Systematic Review and Meta-analysis

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination

Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 from Adults to Children

Household Transmission of SARS-CoV-2: Mortality Weekly Report Transmission of SARS-COV-2 Infections in Households-Tennessee and Wisconsin

Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools

Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection

Estimating infectiousness throughout SARS-CoV-2 infection course. Science (80-)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults with Early Acute Coronavirus Disease 2019 (COVID-19)

The size and concentration of droplets generated by coughing in human subjects

A Pediatric Infectious Disease Perspective on COVID-19

Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD

Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells

RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo

The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry

Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children. The Lancet Infectious Diseases. Lancet up of Antibody Responses in Pediatric Patients with COVID-19 up to 9 Months after Infection

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science (80-)

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

The immune system of children: the key to understanding SARS-CoV-2 susceptibility? The Lancet Child and Adolescent Health

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.